Literature DB >> 15911451

The burden of pneumonia in children in the developed world.

Talal Farha1, Anne H Thomson.   

Abstract

There are few comprehensive epidemiological studies of pneumonia in the developed world. Ascertainment and definition are important variables in the estimation of pneumonia incidence both in primary care and from hospital data. The available figures suggest a burden of disease in the order of 10-15 cases/1000 children per year and a hospital admission rate of 1-4/1000 per year. Both incidence and hospital admission are greatest in the youngest children and rapidly fall after the age of 5 years. In a majority of cases of community acquired pneumonia an organism is not identified. Viral infections are common and influenza A, B, respiratory syncitial virus (RSV) and parainfluenza 1, 2 and 3 are the most common viruses identified. Streptococcus pneumoniae is the most common bacterial cause. Broad brush calculations suggest that the NHS cost of childhood pneumonia in England is 6-8 million pound sterling per annum. This does not include family and social costs. There is potential for new vaccine strategies to decrease childhood pneumonia.

Entities:  

Mesh:

Year:  2005        PMID: 15911451     DOI: 10.1016/j.prrv.2005.03.001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  14 in total

1.  Empyema thoracis.

Authors:  Ala Eldin H Ahmed; Tariq E Yacoub
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2010-06-17

Review 2.  13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents.

Authors:  Greg L Plosker
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

3.  Pneumonia in healthy Canadian children and youth: Practice points for management.

Authors:  N Le Saux; Jl Robinson
Journal:  Paediatr Child Health       Date:  2011-08       Impact factor: 2.253

4.  Outcome of children hospitalized with community-acquired pneumonia treated with aqueous penicillin G.

Authors:  Raquel Simbalista; Marcelo Araújo; Cristiana M Nascimento-Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

5.  Trends in pneumonia and influenza-associated hospitalizations in South Korea, 2002-2005.

Authors:  Soon Ae Kim; Paul E Kilgore; Sang-Yi Lee; Batmunkh Nyambat; Moran Ki
Journal:  J Health Popul Nutr       Date:  2011-12       Impact factor: 2.000

6.  Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children.

Authors:  Sandra Rodrigues da Silva; Luane Marques de Mello; Anderson Soares da Silva; Altacílio Aparecido Nunes
Journal:  Rev Paul Pediatr       Date:  2016-03-30

7.  Carers' perspectives on the presentation of community-acquired pneumonia and empyema in children: a case series.

Authors:  Joanna C Crocker; Meirion R Evans; Christopher C Butler; Kerenza Hood; Colin V E Powell
Journal:  BMJ Open       Date:  2012-09-04       Impact factor: 2.692

Review 8.  Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Authors:  Catherine Weil-Olivier; Mark van der Linden; Iris de Schutter; Ron Dagan; Lorenzo Mantovani
Journal:  BMC Infect Dis       Date:  2012-09-07       Impact factor: 3.090

9.  Assessment of a new algorithm in the management of acute respiratory tract infections in children.

Authors:  Seyed Ahmad Tabatabaei; Seyed Alireza Fahimzad; Ahmad Reza Shamshiri; Farideh Shiva; Shadab Salehpor; Shirin Sayyahfar; Ghamartag Khanbabaei; Shahnaz Armin; Sedigheh Rafil Tabatabaei; Alireza Khatami; Maryam Kadivar
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

10.  Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.

Authors:  Jeffrey M Pernica; Ioana Moldovan; Francis Chan; Robert Slinger
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-05       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.